Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
4,807,060
-
Shares change
-
+372,444
-
Total reported value, excl. options
-
$7,893,000
-
Value change
-
+$553,068
-
Put/Call ratio
-
47%
-
Number of buys
-
11
-
Number of sells
-
-11
-
Price
-
$1.64
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2021
37 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q2 2021.
IGC Pharma, Inc. - COM NEW (IGC) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,807,060 shares
.
Largest 10 shareholders include Davy Global Fund Management Ltd (1,114,415 shares), BlackRock Inc. (843,255 shares), VANGUARD GROUP INC (654,272 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (414,446 shares), RENAISSANCE TECHNOLOGIES LLC (298,115 shares), GEODE CAPITAL MANAGEMENT, LLC (272,005 shares), STATE STREET CORP (216,878 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (209,000 shares), Virtu Financial LLC (190,293 shares), and DEARBORN PARTNERS LLC (96,901 shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.